Eli Lilly invests €35m in Kinsale

US pharmaceutical company Eli Lilly is to invest €35m in a new hi-tech manufacturing facility at its Kinsale campus in County Cork.

The facility is expected to be fully operational by early 2017 and has the potential to “transform how medicines are made in the future”, according to the Indiana headquartered firm.

The development will also see the Kinsale site become Eli Lilly’s centre of excellence for continuous manufacturing for Active Pharmaceutical Ingredients (API) worldwide.